CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics.
CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives.
Our Lead Product
Our lead product is an anti-cancer DNA vaccine, Elenagen™, which is effective against a
broad spectrum of primary tumors and metastatic processes. We believe, Elenagen™
is the only anti-cancer biological, which combines two mechanisms of action,
stimulating anti-cancer immunity and mitigating chronic inflammation.
The CureLab Oncology team has completed its
international Phase I/IIa Clinical Trials of our anti-cancer vaccine Elenagen™ .The
vaccine demonstrated high degree of safety as well as clinical benefits in a
number of patients. Based off the success of these results, we plan to initiate Phase II Clinical Trials in US and other